Literature DB >> 16495040

The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team.

G K Crompton1, P J Barnes, M Broeders, C Corrigan, L Corbetta, R Dekhuijzen, J C Dubus, A Magnan, F Massone, J Sanchis, J L Viejo, T Voshaar.   

Abstract

Although the principles of asthma management are well established in Europe, the available data indicate that asthma in patients is not well controlled. Many patients derive incomplete benefit from their inhaled medication because they do not use inhaler devices correctly and this may compromise asthma control. The Aerosol Drug Management Improvement Team (ADMIT), incorporating clinicians from the UK, Germany, France, Italy, Spain and The Netherlands, reviewed published evidence to examine ways to improve the treatment of reversible airways disease in Europe. Data indicate that there is a clear need for specific training of patients in correct inhalation technique for the various devices currently available, and this should be repeated frequently to maintain correct inhalation technique. Devices which provide reassurance to patients and their physicians that inhalation is performed correctly should help to improve patient compliance and asthma control. Educational efforts should also focus on primary prescribers of inhaler devices. ADMIT recommends dissemination of information on the correct inhalation technique for each model of device by the use of an accessible dedicated literature base or website which would enable to match the appropriate inhaler to the individual patient. There is also a need for standardisation of prescribing practices throughout Europe. Regular checking of inhalation technique by prescribers is crucial as correct inhalation is one of the keystones of successful asthma management.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16495040     DOI: 10.1016/j.rmed.2006.01.008

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  66 in total

1.  Real-world asthma management with inhaler devices in Switzerland-results of the asthma survey.

Authors:  Christian F Clarenbach; Laurent P Nicod; Malcolm Kohler
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

2.  A nurse-led intervention study: Promoting compliance with Diskus Inhaler use in asthma patients.

Authors:  Elaine Mac Hale; Richard W Costello; Seamus Cowman
Journal:  Nurs Open       Date:  2014-11-28

3.  Acoustic Analysis of Inhaler Sounds From Community-Dwelling Asthmatic Patients for Automatic Assessment of Adherence.

Authors:  Martin S Holmes; Shona D'arcy; Richard W Costello; Richard B Reilly
Journal:  IEEE J Transl Eng Health Med       Date:  2014-03-11       Impact factor: 3.316

Review 4.  What can be done to impact respiratory inhaler misuse: exploring the problem, reasons, and solutions.

Authors:  Anna Volerman; Delesha Carpenter; Valerie Press
Journal:  Expert Rev Respir Med       Date:  2020-04-28       Impact factor: 3.772

5.  Study of inhaler technique in asthma patients: differences between pediatric and adult patients.

Authors:  Pablo Manríquez; Ana María Acuña; Luis Muñoz; Alvaro Reyes
Journal:  J Bras Pneumol       Date:  2015 Sep-Oct       Impact factor: 2.624

6.  Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters.

Authors:  L Pekka Malmberg; Paula Rytilä; Pertti Happonen; Tari Haahtela
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-08-09

7.  Comparing usability of NEXThaler(®) with other inhaled corticosteroid/long-acting β2-agonist fixed combination dry powder inhalers in asthma patients.

Authors:  Thomas Voshaar; Monica Spinola; Patrick Linnane; Alice Campanini; Daniel Lock; Anthony Lafratta; Mario Scuri; Barbara Ronca; Andrea S Melani
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2013-12-03       Impact factor: 2.849

8.  Evaluation of in vitro and in vivo flow rate dependency of budesonide/formoterol Easyhaler(®).

Authors:  L Pekka Malmberg; Mark L Everard; Jussi Haikarainen; Satu Lähelmä
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2014-06-30       Impact factor: 2.849

9.  Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir(®) Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies.

Authors:  Edward M Kerwin; Herminia Taveras; Harald Iverson; Denise Wayne; Tushar Shah; Mark S Lepore; David S Miller
Journal:  Clin Drug Investig       Date:  2016-01       Impact factor: 2.859

10.  Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control.

Authors:  Mike Thomas; David Price; Henry Chrystyn; Andrew Lloyd; Angela E Williams; Julie von Ziegenweidt
Journal:  BMC Pulm Med       Date:  2009-01-02       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.